3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Head and Neck Neoplasms
1
Gastric Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Adenoma
1
Interventions
Magnetic Resonance Spectroscopy
8
Specimen Handling
5
Nivolumab
5
selpercatinib
4
Iodine-124
4
Biopsy
4
pembrolizumab
3
binimetinib
3
Iodine-131
3
Cetuximab
3
trametinib
2
omipalisib
2
lenvatinib
2
larotrectinib
2
durvalumab
2
defactinib
2
dabrafenib
2
Surveys and Questionnaires
2
Sunitinib
2
Radiosurgery
2
Ipilimumab
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
ulixertinib
1
tremelimumab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Indocyanine Green
×
90 days
×
Clear all
No trials found.